These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 28720325)

  • 1. Therapeutic peptides: Historical perspectives, current development trends, and future directions.
    Lau JL; Dunn MK
    Bioorg Med Chem; 2018 Jun; 26(10):2700-2707. PubMed ID: 28720325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future directions for peptide therapeutics development.
    Kaspar AA; Reichert JM
    Drug Discov Today; 2013 Sep; 18(17-18):807-17. PubMed ID: 23726889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and Peptide Biopharmaceuticals: An Overview.
    Agyei D; Ahmed I; Akram Z; Iqbal HM; Danquah MK
    Protein Pept Lett; 2017; 24(2):94-101. PubMed ID: 28017145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide therapeutics from venom: Current status and potential.
    Pennington MW; Czerwinski A; Norton RS
    Bioorg Med Chem; 2018 Jun; 26(10):2738-2758. PubMed ID: 28988749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current trends in the clinical development of peptide therapeutics.
    Saladin PM; Zhang BD; Reichert JM
    IDrugs; 2009 Dec; 12(12):779-84. PubMed ID: 19943221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and therapeutic potential of venom peptides.
    Robinson SD; Vetter I
    Biochem Pharmacol; 2020 Nov; 181():114207. PubMed ID: 32857993
    [No Abstract]   [Full Text] [Related]  

  • 7. Venoms as a platform for human drugs: translating toxins into therapeutics.
    King GF
    Expert Opin Biol Ther; 2011 Nov; 11(11):1469-84. PubMed ID: 21939428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics.
    Erak M; Bellmann-Sickert K; Els-Heindl S; Beck-Sickinger AG
    Bioorg Med Chem; 2018 Jun; 26(10):2759-2765. PubMed ID: 29395804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate.
    Anand U; Bandyopadhyay A; Jha NK; Pérez de la Lastra JM; Dey A
    Biofactors; 2023 Mar; 49(2):251-269. PubMed ID: 36326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
    Robinson SD; Undheim EAB; Ueberheide B; King GF
    Expert Rev Proteomics; 2017 Oct; 14(10):931-939. PubMed ID: 28879805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building on Success: A Bright Future for Peptide Therapeutics.
    Angell Y; Holford M; Moos WH
    Protein Pept Lett; 2018; 25(12):1044-1050. PubMed ID: 30430932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serendipity in Cancer Drug Discovery: Rational or Coincidence?
    Prasad S; Gupta SC; Aggarwal BB
    Trends Pharmacol Sci; 2016 Jun; 37(6):435-450. PubMed ID: 27083322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in peptide drug discovery.
    Muttenthaler M; King GF; Adams DJ; Alewood PF
    Nat Rev Drug Discov; 2021 Apr; 20(4):309-325. PubMed ID: 33536635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and challenges in the optimization of toxin peptides for development as pain therapeutics.
    Netirojjanakul C; Miranda LP
    Curr Opin Chem Biol; 2017 Jun; 38():70-79. PubMed ID: 28376346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.
    Hutchings CJ; Koglin M; Olson WC; Marshall FH
    Nat Rev Drug Discov; 2017 Sep; 16(9):787-810. PubMed ID: 28706220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Regulatory Challenges for Peptide Therapeutics.
    Zane D; Feldman PL; Sawyer T; Sobol Z; Hawes J
    Int J Toxicol; 2021; 40(2):108-124. PubMed ID: 33327828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-target drug discovery in medicinal chemistry: current status and future perspectives.
    Speck-Planche A; Cordeiro MN
    Mini Rev Med Chem; 2015; 15(8):606-7. PubMed ID: 25694079
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress with peptide scanning to study structure-activity relationships: the implications for drug discovery.
    Eustache S; Leprince J; Tufféry P
    Expert Opin Drug Discov; 2016 Aug; 11(8):771-84. PubMed ID: 27310575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides-staple method development and its application in cancer therapy.
    Zhang QZ; Tian Y; Lao YZ; Li ZG
    Curr Med Chem; 2014; 21(21):2438-52. PubMed ID: 24524768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.